Resources

  • References

    Allergan Physician Production Information. Botox cosmetic (botulinum toxin type A). Published April 2008.

    FDA approves Botox to treat chronic migraines. US Food & Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229782.htm. Published October 15, 2010. Accessed February 12, 2014.


    Ondo WG, Gollomp S, Galvez-Jimenez N. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Headache. 2005;45(8):1073-1077.


    Ward A, Roberts G, Warner J, et al. Cost-effectiveness of botulinum toxin type A in the treatment of post-stroke spasticity.
    J Rehabil Med. 2005;37(4):252-257.


    11/4/2009 DynaMed Systematic Literature Surveillance
    http://www.ebscohost.com/dynamed: FDA gives update on botulinum toxin safety warnings. US Food and Drug Administration website. Available at:
    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm175013.htm. Updated August 3, 2009. Accessed November 4, 2009.


    3/19/2010 DynaMed Systematic Literature Surveillance
    http://www.ebscohost.com/dynamed: FDA approves Botox to treat spasticity in flexor muscles of the elbow, wrist and fingers. US Food and Drug Administration website. Available at:
    http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm203776.htm. Updated March 9, 2010. Accessed March 19, 2010.


    5/17/2012 DynaMed's Systematic Literature Surveillance
    http://www.ebscohost.com/dynamed: Jackson JL, Kuriyama A, Hayashino Y. Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.
    JAMA.
    2012;307(16):1736-1745.

  • Resources

    American Society for Dermatologic Surgery

    http://www.asds.net

    American Society of Plastic Surgeons

    http://www.plasticsurgery.org

  • Canadian Resources

    Canadian Dermatology Association

    http://www.dermatology.ca